Home > Press > ISE-CCM Nanotechnology Index is down -6.29% Year to Date
The ISE-CCM Nanotechnology Index (ISE: TNY) is down -6.29% year to date, versus 3.63% for the S&P 500, 7.29% for the DJIA, and 5.90% for the Nasdaq.
ISE-CCM Nanotechnology Index is down -6.29% Year to Date
New York, NY | Posted on September 12th, 2007
TNY was co-developed by Cronus Capital Markets and the International Securities Exchange (ISE) in New York. TNY comprises 17 of the leading Nanotechnology companies such as; Cabot Corp. (NYSE: CBT), Headwaters Inc. (NYSE: HW), Symyx Technologies Inc. (NASDAQ: SMMX), and FEI COMPANY (NASDAQ: FEIC). TNY is currently trading options in the ISE.
Cronus Capital Markets CEO Michael Soni remarked that "monthly index reports are an important feature of CCM's Index Support Program, especially for an index like TNY which covers an important aspect of the capital markets and receives significant investor interest."
CCM Index Reports, available at no cost to investors and the media, include index descriptions, objectives, volatility analysis, performance returns, product specifications, component breakdowns and component profiles with news links. The TNY report is available on www.iseoptions.com
About Cronus Capital Markets
Cronus Capital Markets® (CCM) is a global investment information firm who strategically produces and introduces, through various forms of analytics and worldwide distribution, information on equity market opportunities. Our equity indexes receive international attention and represent important new benchmarks of growth.
For more information, please click here
Copyright © Cronus Capital Markets®
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Notes ABSMaterials' Series B Financing November 22nd, 2013
Harris & Harris Group Letter to Shareholders on Website November 18th, 2013
Harris & Harris Group Reports Financial Statements as of September 30, 2013 November 12th, 2013
Harris & Harris Group Notes CordenPharma's Acquisition of Ancora's Carbohydrate Synthesis Platform and Corporate Name November 7th, 2013
Leti Presentation at IEDM 2013 Will Report Phase-Change Memory Developments for Microcontroller Embedded Applications December 7th, 2013
Leti Announces Update of UTSOI Model that Allows Designers To Improve Trade-Off between Performance and Power Use December 7th, 2013
Steve Janack to Join Behan Communications and Lead Firm’s New Innovation Practice Group December 7th, 2013
Optical Quality Improvement of Electrical Circuits’ Electrode Zinc Oxide Nanowires December 7th, 2013